Skip to main content

Volume 24 - Issue 1 - January 2012

Clinical Images
01/05/2012
Brian K. Eble, MD; Rajesh Sachdeva, MD
Abstract: In Kawasaki disease, coronary aneurysms typically regress slowly, although some may develop stenosis 1-2 decades after the acute illness. This is the first case report describing rapid progression of coronary aneurysm to stenosis...
Abstract: In Kawasaki disease, coronary aneurysms typically regress slowly, although some may develop stenosis 1-2 decades after the acute illness. This is the first case report describing rapid progression of coronary aneurysm to stenosis...
Abstract: In Kawasaki disease,...
01/05/2012
Journal of Invasive Cardiology
Tips and Techniques
01/05/2012
Jigar Patel, MD; Reji Pappy, MD; Mazen S. Abu-Fadel, MD
Abstract: The Trellis thrombectomy system (Covidien) has been used successfully to perform isolated pharmacomechanical thrombectomy of both venous and arterial thrombi. The device is designed to provide localized treatment while preventing...
Abstract: The Trellis thrombectomy system (Covidien) has been used successfully to perform isolated pharmacomechanical thrombectomy of both venous and arterial thrombi. The device is designed to provide localized treatment while preventing...
Abstract: The Trellis...
01/05/2012
Journal of Invasive Cardiology
Review
01/05/2012
Neeraj Jolly, MD, DM; Sandra A. Weiss, MD
Abstract: Percutaneous ventricular assist devices are increasingly used today, allowing the scope of left ventricular support to move out of the operating room and into the interventional suite and cardiovascular care unit. This has given...
Abstract: Percutaneous ventricular assist devices are increasingly used today, allowing the scope of left ventricular support to move out of the operating room and into the interventional suite and cardiovascular care unit. This has given...
Abstract: Percutaneous...
01/05/2012
Journal of Invasive Cardiology
Original Contribution
01/05/2012
Søren Galatius, MD, DMSc; Anders Hvelplund, MD; Mette Madsen, MSc; Rikke Sorensen, MD, PhD; Hans-Henrik Tilsted, MD, PhD; Steffen Helqvist, MD, PhD; Poul Erik Mortensen, MD; Per Hostrup Nielsen, MD; Eva Prescott, MD, DMSc; Steen Zabell Abildstrom, MD, PhD; Jan Kyst Madsen, MD, DMSc; Allan Zeeberg Iversen, MD, PhD
Abstract: Objective. To describe gender-specific long-term outcome and initiation of secondary preventive medication among patients with acute myocardial infarction (AMI). Design. Observational cohort study. Setting. Nationwide registries....
Abstract: Objective. To describe gender-specific long-term outcome and initiation of secondary preventive medication among patients with acute myocardial infarction (AMI). Design. Observational cohort study. Setting. Nationwide registries....
Abstract: Objective. To describe...
01/05/2012
Journal of Invasive Cardiology
Commentary
01/04/2012
Vankeepuram S. Srinivas, MBBS, MS; Maulik Patel, MD
One of the cornerstones of contemporary stent implantation during percutaneous coronary revascularization is the need for adequate stent expansion with apposition of stent struts to the vessel wall. In most cases, this is achieved with...
One of the cornerstones of contemporary stent implantation during percutaneous coronary revascularization is the need for adequate stent expansion with apposition of stent struts to the vessel wall. In most cases, this is achieved with...
One of the cornerstones of...
01/04/2012
Journal of Invasive Cardiology
Original Contribution
01/04/2012
Katsuhisa Waseda, MD, PhD; Ichizo Tsujino, MD, PhD; Teruyoshi Kume, MD, PhD; Kenji Sakata, MD; Takao Shimohama, MD, PhD; Takao Hasegawa, MD; Junya Ako, MD, PhD; Yasuhiro Honda, MD; Peter J. Fitzgerald, MD, PhD; Masao Yamasaki, MD, PhD
Abstract: Background. There has been no detailed intravascular ultrasound (IVUS) analysis to evaluate the degree to which stent underexpansion or reference vessel/stent size mismatch contributes to the occurrence of post-procedural incomplete...
Abstract: Background. There has been no detailed intravascular ultrasound (IVUS) analysis to evaluate the degree to which stent underexpansion or reference vessel/stent size mismatch contributes to the occurrence of post-procedural incomplete...
Abstract: Background. There has...
01/04/2012
Journal of Invasive Cardiology
Original Contribution
01/04/2012
William M. Gottliebson, MD, MS; Paul Succop, PhD; Massoud A. Leesar, MD, FACC; Imran Arif, MD; Srikara V. Peelukhana, MS; Kranthi K. Kolli, MS; Tarek A. Helmy, MD; Mohamed A. Effat, MD; Rupak K. Banerjee, PhD, PE; Eric W. Schneeberger, MD
Abstract: Objectives and Background. Decisions based on invasive functional diagnostic measurements are often made in the setting of fluctuating hemodynamic variables that may alter resting or hyperemic measurements. The purpose of this...
Abstract: Objectives and Background. Decisions based on invasive functional diagnostic measurements are often made in the setting of fluctuating hemodynamic variables that may alter resting or hyperemic measurements. The purpose of this...
Abstract: Objectives and...
01/04/2012
Journal of Invasive Cardiology
Commentary
01/04/2012
Tarek A. Helmy, MD; Arumugam Narayanan, MD; Mouhamad Abdallah, MD
Saphenous vein grafts (SVG) are commonly used conduits for coronary bypass, with a graft failure rate of up to 45% per patient and 29% per graft on angiographic follow-up at 18 months.1 Atherosclerotic plaques in SVGs tend to be bulky,...
Saphenous vein grafts (SVG) are commonly used conduits for coronary bypass, with a graft failure rate of up to 45% per patient and 29% per graft on angiographic follow-up at 18 months.1 Atherosclerotic plaques in SVGs tend to be bulky,...
Saphenous vein grafts (SVG) are...
01/04/2012
Journal of Invasive Cardiology
01/05/2012
Bryan G. Schwartz, MD; Daniel J. Ludeman, BS; Steven Burstein, MD
ABSTRACT: The Impella LP 2.5 left ventricular assist device (Abiomed) is safe and effective for assisting high-risk percutaneous interventions. A 77-year-old woman with severe aortic stenosis, severe coronary artery disease, an ejection...
ABSTRACT: The Impella LP 2.5 left ventricular assist device (Abiomed) is safe and effective for assisting high-risk percutaneous interventions. A 77-year-old woman with severe aortic stenosis, severe coronary artery disease, an ejection...
ABSTRACT: The Impella LP 2.5...
01/05/2012
Journal of Invasive Cardiology
Original Contribution
01/04/2012
Harsh Golwala, MD; Beau M. Hawkins, MD; Stavros Stavrakis, MD, PhD; Mazen S. Abu-Fadel, MD
Abstract: Background. Percutaneous treatment of saphenous vein graft disease is hampered by high rates of periprocedural myocardial infarction (MI). The use of embolic protection devices (EPD) during these interventions is a class IB...
Abstract: Background. Percutaneous treatment of saphenous vein graft disease is hampered by high rates of periprocedural myocardial infarction (MI). The use of embolic protection devices (EPD) during these interventions is a class IB...
Abstract: Background....
01/04/2012
Journal of Invasive Cardiology